Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis
NCT00570661
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Active Systemic
Onset Juvenile Idiopathic Arthritis
Interventions
DRUG:
ITF2357
Sponsor
Italfarmaco